CM
RMD icon

Caption Management’s ResMed RMD Stock Holding History

Caption Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-17,500
Closed -$3.92M – 1823
2025
Q1 		$3.92M Buy
+17,500
New +$4.09M 0.04% 477
2024
Q2 		– Sell
-110,700
Closed -$21.9M – 1448
2024
Q1 		$21.9M Buy
+110,700
New +$20.3M 0.33% 58
2022
Q2 		– Sell
-15,000
Closed -$3.64M – 1766
2022
Q1 		$3.64M Buy
+15,000
New +$3.63M 0.04% 550

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Caption Management's RMD Position: Q2 2025 in Review

Caption Management sold out of ResMed (RMD) in Q2 2025, closing a stake of 4,000 shares — an estimated $895K sold.

Caption Management first reported a position in RMD in Q3 2020 and held it in 3 quarters. The position peaked at $1.94M in Q1 2022. 920 funds tracked by Wall St. Rank hold RMD as of Q2 2025.

  • Caption Management reported no remaining ResMed position as of Q2 2025 after selling out during the quarter.
  • Caption Management sold 4,000 ResMed shares in Q2 2025, an estimated $895K.
  • Caption Management first reported a position in ResMed in Q3 2020 and held it in 3 quarters.
  • Caption Management's ResMed position peaked at $1.94M in Q1 2022.
  • 920 funds tracked by Wall St. Rank held ResMed as of Q2 2025.

Based on Caption Management's 13F filing for Q2 2025, filed 14 Aug 2025.